Disease Clusters?

Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.

← Back to all clusters

Cluster 512

5 diseases · 9 shared-gene connections
5 Diseases
19 Unique genes
0.172 Avg. similarity score
Disorders of sex development Most-connected disease (4 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Disease ⇵ Connections in cluster ⇵ Significant partners ⇵ Curated genes ⇵
Disorders of sex development 4 4 8
Familial male precocious puberty 4 4 1
Luteinizing hormone resistance 4 4 1
46,xy disorder of sex development 3 3 11
Testotoxicosis 3 3 4

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
LHCGR 5 / 5 46,xy disorder of sex development, Disorders of sex development, Familial male precocious puberty, Luteinizing hormone resistance and 1 more
AKR1C2 2 / 5 46,xy disorder of sex development, Disorders of sex development
HSD17B3 2 / 5 46,xy disorder of sex development, Disorders of sex development
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Steroid hormone biosynthesis
HSD17B3, SRD5A2, CYP17A1, AKR1C2, AKR1C4, CYP11A1, AKR1C1, AKR1C3
 KEGG 8 / 63 80.3× 2.61e-14 6.89e-12 ✓ sig.
Synthesis of bile acids and bile salts via 24-hydroxycholesterol
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 Reactome 4 / 14 181× 4.43e-9 3.57e-7 ✓ sig.
Synthesis of bile acids and bile salts via 27-hydroxycholesterol
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 Reactome 4 / 15 169× 6.04e-9 4.71e-7 ✓ sig.
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 Reactome 4 / 24 105× 4.66e-8 2.86e-6 ✓ sig.
Androgen biosynthesis
HSD17B3, SRD5A2, CYP17A1
 Reactome 3 / 11 172× 5.49e-7 2.48e-5 ✓ sig.
Ovarian steroidogenesis
CYP17A1, CYP11A1, LHCGR, AKR1C3
 KEGG 4 / 52 48.6× 1.15e-6 4.73e-5 ✓ sig.
Retinoid metabolism and transport
AKR1C4, AKR1C1, AKR1C3
 Reactome 3 / 41 46.3× 3.45e-5 8.12e-4 ✓ sig.
Cortisol synthesis and secretion
CYP17A1, CYP11A1, NR5A1
 KEGG 3 / 65 29.2× 1.38e-4 2.44e-3 ✓ sig.
Glycoprotein hormones
INHA, INHBB
 Reactome 2 / 12 105× 1.55e-4 2.68e-3 ✓ sig.
Prolactin signaling pathway
CYP17A1, LHCGR, ESR2
 KEGG 3 / 71 26.7× 1.79e-4 3.01e-3 ✓ sig.
Metabolic pathways
HSD17B3, SRD5A2, CYP17A1, AKR1C2, AKR1C4, CYP11A1, AKR1C1, AKR1C3, DHCR7
 KEGG 9 / 1,563 3.6× 2.83e-4 4.31e-3 ✓ sig.
Chemical carcinogenesis - reactive oxygen species
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 KEGG 4 / 227 11.1× 3.85e-4 5.46e-3 ✓ sig.
Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
CYP17A1
 Reactome 1 / 1 632× 1.58e-3 1.60e-2 ✓ sig.
Cushing syndrome
CYP17A1, CYP11A1, NR5A1
 KEGG 3 / 155 12.2× 1.76e-3 1.73e-2 ✓ sig.
Nuclear Receptor transcription pathway
NR5A1, ESR2
 Reactome 2 / 52 24.3× 3.00e-3 2.54e-2 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
hormone metabolic process
CYP17A1, AKR1C2, AKR1C4, NR5A1, AKR1C1, AKR1C3
 GO:0042445 6 / 25 236× 8.04e-14 4.73e-11 ✓ sig.
progesterone metabolic process
CYP17A1, AKR1C2, AKR1C4, AKR1C1, AKR1C3
 GO:0042448 5 / 10 492× 1.54e-13 8.51e-11 ✓ sig.
steroid metabolic process
SRD5A2, CYP17A1, AKR1C2, AKR1C4, CYP11A1, AKR1C1, AKR1C3, DHCR7
 GO:0008202 8 / 135 58.3× 4.25e-13 2.14e-10 ✓ sig.
cellular response to jasmonic acid stimulus
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 GO:0071395 4 / 4 984× 7.63e-13 3.67e-10 ✓ sig.
alcohol metabolic process
AKR1C2, AKR1C4, CYP11A1, AKR1C1, AKR1C3
 GO:0006066 5 / 18 273× 5.21e-12 2.11e-9 ✓ sig.
male gonad development
DMRT1, SRD5A2, LHCGR, NR5A1, AKR1C3, INHA, INHBB
 GO:0008584 7 / 117 58.8× 1.49e-11 5.48e-9 ✓ sig.
daunorubicin metabolic process
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 GO:0044597 4 / 9 437× 9.58e-11 2.95e-8 ✓ sig.
doxorubicin metabolic process
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 GO:0044598 4 / 10 393× 1.60e-10 4.64e-8 ✓ sig.
monocarboxylic acid metabolic process
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 GO:0032787 4 / 17 231× 1.80e-9 3.88e-7 ✓ sig.
steroid biosynthetic process
HSD17B3, SRD5A2, CYP17A1, CYP11A1, DHCR7
 GO:0006694 5 / 65 75.7× 4.87e-9 9.37e-7 ✓ sig.
sex differentiation
DMRT1, SRD5A2, CYP17A1, AMH
 GO:0007548 4 / 26 151× 1.12e-8 1.95e-6 ✓ sig.
testosterone biosynthetic process
HSD17B3, SRD5A2, AKR1C3
 GO:0061370 3 / 6 492× 1.78e-8 2.91e-6 ✓ sig.
prostaglandin metabolic process
AKR1C2, AKR1C4, AKR1C1, AKR1C3
 GO:0006693 4 / 30 131× 2.06e-8 3.30e-6 ✓ sig.
lipid metabolic process
HSD17B3, SRD5A2, CYP17A1, AKR1C2, AKR1C4, CYP11A1, AKR1C1, AKR1C3, DHCR7
 GO:0006629 9 / 840 10.5× 4.42e-8 6.39e-6 ✓ sig.
androgen biosynthetic process
HSD17B3, SRD5A2, CYP17A1
 GO:0006702 3 / 9 328× 7.46e-8 9.97e-6 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
46,xy disorder of sex development Disorders of sex development 0.176 3 1.49e-8 1.16e-7 ✓ sig.
Familial male precocious puberty Luteinizing hormone resistance 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Familial male precocious puberty Testotoxicosis 0.200 1 2.58e-4 5.38e-4 ✓ sig.
Luteinizing hormone resistance Testotoxicosis 0.200 1 2.58e-4 5.38e-4 ✓ sig.
Disorders of sex development Familial male precocious puberty 0.111 1 5.17e-4 9.13e-4 ✓ sig.
Disorders of sex development Luteinizing hormone resistance 0.111 1 5.17e-4 9.13e-4 ✓ sig.
46,xy disorder of sex development Familial male precocious puberty 0.083 1 7.10e-4 1.17e-3 ✓ sig.
46,xy disorder of sex development Luteinizing hormone resistance 0.083 1 7.10e-4 1.17e-3 ✓ sig.
Disorders of sex development Testotoxicosis 0.083 1 2.06e-3 2.79e-3 ✓ sig.